Investing In Your Vices

You may love weed, alcohol, and tobacco, but would you also like to invest in those things? AdvisorShares thinks you will. The actively managed exchange-traded funds company recently launched AdvisorShares VICE ETF, the only ETF solely concentrating on companies associated with alcohol, cannabis, and tobacco. Dan Ahrens is a Managing Director and Portfolio Manager at AdvisorShares, and he joins Cheddar to explain why investing in the VICE ETF is a good idea. Ahrens explains that those three industries tend to be stable despite the general market volatility. Ahrens is also bullish on the future of cannabis. He believes the legalization and federal recognition of the substance will only expand. As for alcohol, there has also been growth in that field. The alcohol industry had supplier revenue increase by 4.5% to $25.2 billion last year. Ahrens anticipates the field to continue improving.

More In Business

The Economic ‘Pain’ Fed Chief Jerome Powell Warned About Is Here

Data shows the economy grew less than expected in the first three months of the year, as consumers became more price conscious and spent less.

Will Live Nation and Ticketmaster Actually Be Broken Up?

The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!

The Future of Ether ETFs After That SEC Ruling

CoinShares CEO, Jean-Marie Mognetti, joins Cheddar to discuss what's next for ether ETFs and other cryptocurrency after the SEC surprise ruling.

The Trending, Fastest-Growing Summer Destinations Will Surprise You

From the Vegas strip to breathtaking national parks, we’re obsessed.

Nvidia's Blockbuster Run Is Just Getting Started

Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.

Perspective Therapeutics Is Creating New Ways to Fight Cancer

In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d

When It Comes to the Economy, There’s ‘A Lot to Be Optimistic About’

Business is booming, interest rate cuts aren’t desperately needed, and, consumers are in what one analyst calls ‘pretty good shape.’

More People Are Making 'no-buy year' Pledges. Should You?

The self-imposed rules of a no-buy challenge are simple: participants pledge to stop buying non-essential items.

Forget Inflation: American Consumers Want Travel and Experiences

Americans may be exhausted by inflation, but they aren't holding back when to comes to spending on travel and experiences.

The U.S. Can Avoid a Recession – But Higher Prices Are Here to Stay

Companies like Target, Walmart, and Amazon may be cutting prices – but consumers should get used to paying more than they did pre-pandemic.

Load More